5/7/24 21:52 | 5/7/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | M.d | 35 | 1.24 | 0 | 28 | 33 | 112 | D | | | | | | | | | | | | | | |
5/7/24 21:52 | 5/7/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.d | -715 | 25.54 | 0 | -28 | -20 | 112 | D | | | | | | | | | | | | | | |
4/3/24 18:16 | 4/2/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | M.d | 35 | 1.24 | 0 | 28 | 33 | 112 | D | | | | | | | | | | | | | | |
4/3/24 18:16 | 4/2/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.d | -735 | 26.25 | 0 | -28 | -20 | 112 | D | | | | | | | | | | | | | | |
3/12/24 17:29 | 3/8/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | M.dm | 139 | 1.24 | 0 | 112 | 999% | 112 | D | | | | | | | | | | | | | | |
3/12/24 17:29 | 3/8/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.dm | -2,430 | 21.70 | 0 | -112 | -50 | 112 | D | | | | | | | | | | | | | | |
3/5/24 16:53 | 3/1/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | M.d | 104 | 1.24 | 0 | 84 | 299 | 112 | D | | | | | | | | | | | | | | |
3/5/24 16:53 | 3/1/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.d | -1,691 | 20.13 | 0 | -84 | -43 | 112 | D | | | | | | | | | | | | | | |
1/23/24 15:13 | 1/22/24 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.d | -52 | 10.13 | 0 | -5 | -10 | 44 | D | | | | | | | | | | | | | | |
2/3/23 17:26 | 2/1/23 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | M.dm | 62 | 1.24 | 0 | 50 | 999% | 53 | D | | | | | | | | | | | | | | |
2/3/23 17:26 | 2/1/23 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.dm | -1,218 | 24.35 | 0 | -50 | -48 | 53 | D | | | | | | | | | | | | | | |
11/14/22 16:30 | 11/9/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Boyce Sarah | CA | D | | P.m | 101 | 2.82 | 0 | 36 | 69 | 88 | I | | | | | | | | | | | | | | |
8/26/22 19:29 | 8/24/22 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | M.dm | 62 | 1.24 | 0 | 50 | | 0 | D | | | | | | | | | | | | | | |
8/26/22 19:29 | 8/24/22 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.dm | -1,142 | 22.88 | 0 | -50 | -100 | 0 | D | | | | | | | | | | | | | | |
8/17/22 21:40 | 8/15/22 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | M.d | 0 | 1.24 | 0 | 0 | | 0 | D | | | | | | | | | | | | | | |
8/17/22 21:40 | 8/15/22 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | S.d | -2 | 22.47 | 0 | 0 | -100 | 0 | D | | | | | | | | | | | | | | |